UnknownNCT04962334
Official study titleEffect of Nutritional Formula Supplementation on Growth of Prepubertal Children Treated With Stimulants Medications for ADHD. A Randomized Double-blind, Placebo-controlled Trial
Current recruitment status is unconfirmed.
In Petah TikvaADHDPlacebo comparisonUp to age 10
- Countries
- Israel
- Sponsor
- Rabin Medical Center
TerminatedNCT02638168
Official study titleEffects of Evening Dose of Immediate Release Methylphenidate on Sleep in Children With Attention Deficit Hyperactivity Disorder: A Randomized Placebo-controlled Pilot Study
This study ended early.
In HersheyADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Milton S. Hershey Medical Center
CompletedNCT00150579
Official study titleA Phase III, Randomized, Double-blind, Multi-center, Placebo-Controlled, Parallel-Group, Safety and Efficacy Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD).
This study has finished and is no longer accepting participants.
Location not clearly listedADHDMedication studyAges 18–55
- Countries
- Sponsor
- Shire
CompletedNCT00152022
Official study titleA Phase III, Randomized, Double-blind, Multi-center, Placebo-controlled, Parallel-Group, Safety and Efficacy Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD).
This study has finished and is no longer accepting participants.
Location not clearly listedADHDMedication studyAges 18–55
- Countries
- Sponsor
- Shire
CompletedNCT03446885
Official study titleEfficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With Attention-deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In BuffaloADHDMedication studyAges 16–25
- Countries
- United States
- Sponsor
- Gregory Fabiano
CompletedNCT00151970
What is this study about?This study evaluated the safety and effectiveness of Methylphenidate Transdermal System for people with ADHD.
This study has finished and is no longer accepting participants.
Location not clearly listedADHDMedication studyAges 6–12
- Countries
- Sponsor
- Noven Therapeutics
TerminatedNCT04823364
Official study titleMeasuring Glutamate and GABA Brain Levels in Adults With Attention Deficit Hyperactivity Disorder (ADHD) Using Magnetic Resonance Spectroscopy (MRS)
This study ended early.
Multiple locations, including Kfar SabaADHDInterventional studyAges 18–40
- Countries
- Israel
- Sponsor
- Weizmann Institute of Science
CompletedNCT01721720
Official study titleThe Neurobehavioral, Environmental and Genetic Factors Impacting the Clinical Course of Attention Deficit Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In BethesdaADHDObservational studyAges 3+
- Countries
- United States
- Sponsor
- National Human Genome Research Institute (NHGRI)
Active Not RecruitingNCT07510152
Official study titleEffectiveness of an Educational Program on Primary School Teachers' Knowledge and Performance Regarding Attention-Deficit/Hyperactivity Disorder (ADHD)
This study is no longer accepting new participants.
In ErbilADHDBehavioural studyAges 18–59
- Countries
- Iraq
- Sponsor
- Dlniya Ismail Rashid
CompletedNCT03250013
Official study titleLong-term Effects of Medication for Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents on Cognition, Everyday Function and Quality of Life
This study has finished and is no longer accepting participants.
In GothenburgADHDMedication studyAges 6–17
- Countries
- Sweden
- Sponsor
- Göteborg University
CompletedNCT02808104
What is this study about?This study evaluated the safety and effectiveness of mazindol for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Newport BeachADHDMedication studyAges 18–65
- Countries
- United States
- Sponsor
- NLS Pharmaceutics
CompletedNCT00307684
What is this study about?Researchers compared open label PR OROS methylphenidate, double blind PR OROS methylphenidate and placebo, tracking side effects to assess long-term safety and tolerability in adults with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including ParisADHDMedication studyAges 18–65
- Countries
- France, Switzerland, Germany, + 4 others
- Sponsor
- Janssen-Cilag International NV